Dr. Shad Helmstetter, Ph.D., founder of the Self Talk Institute and best-selling author of more than twenty-five books in the field of mental health and personal growth, including the classic “What to Say When You Talk to Your Self,” “Negative Self-Talk and How to Change It” and the “365 Days of Positive Self-Talk” series discusses his new SelfTalkPlus.com app which helps people learn positive self-talk via self-talk sessions covering all key areas of life including stress and anxiety, weight loss, self-esteem, organization, relationships, finances, dealing with negatives, staying focused, and much more. SelfTalkPlus is for all age groups – from younger children and teens to adults and seniors.
Dr. Anthony Bleyer, a nephrologist at Wake Forest Baptist Health in North Carolina and co-author of this study discusses real-world data shared at the National Kidney Foundation’s Spring Clinical Meeting (April 2021) on KRYSTEXXA (pegloticase injection) use in dialysis patients with advanced renal disease and uncontrolled gout. Previously presented at the American Society of Nephrology 2020 meeting, the data suggests that KRYSTEXXA is well-tolerated as an effective management option for dialysis patients.
Most people who suffer a stroke aren’t treated in time to prevent long-term and often permanent effects on speech, cognition and motor function. Dr. Shahid Nimjee, MD, PhD, a neurosurgeon at The Ohio State University Wexner Medical Center discusses a study providing hope for unprecedented stroke recovery by “retraining” skin cells to become blood vessel cells to help repair damage to brain tissue. Researchers studied the process in mice and found that those treated with this innovative cell therapy regained 90% of their motor function. MRI imaging showed damaged areas of the brain were repaired within a few weeks. The study is published in the journal “Science Advances”.(March 19, 2021)
Dr. Navneet Majhail, M.D., M.S., Director, Blood and Marrow Transplant Program, Cleveland Clinic, and an Incyte Ingenuity Award judge discusses the Incyte Ingenuity Award Program which was created to support people impacted by graft-versus-host disease (GVHD). This condition can occur after an allogeneic stem cell transplant where the donated cells initiate an immune response and attack the transplant recipient’s organs, leading to significant morbidity and mortality. The 2021 Incyte Ingenuity Award program has been expanded to now include a second $35,000 award in addition to the original $100,000 award to better support projects of different scales. Open for entries until June 30, 2021.
Dr. Angelos Stergiou, President and CEO of SELLAS Life Sciences Group, a late-stage clinical biopharmaceutical company discusses their Phase 3 lead asset, Galinpepimut-S (GPS) a novel immunotherapy that helps to prolong overall survival for cancer patients who are in remission as a monotherapy. He talks about the various indications that GPS targets and the company’s focus on the Wilms Tumor 1 (WT1) antigen and why they are the most advanced company working on this in the space.
Dr. Robert Cohen, MD, FACS, board-certified plastic surgeon based in Beverly Hills discusses how and when to advise patients if breast augmentation surgery is something they should be acting on now or waiting for the pandemic to subside and how to schedule surgeries during the pandemic.
Kasey Frey, second-year Arcadia University Doctor of Physical Therapy student, discusses the new student-run physical therapy pro bono clinic at Arcadia, which opened on March 18. The goal of the Glenside, Pa. clinic is to help address healthcare disparities by providing free physical therapy services while giving students a hands-on learning opportunity, while faculty provide oversight. It is open to all community members for preventative care or rehabilitation from injuries or long-term conditions without requiring a doctor’s referral. There are now 108 university-based clinics nationwide.
Amanda L. Bury, Vice President, Strategic Alliances at TeraRecon discusses their role as the leading provider of medical imaging visualization, AI development, and interoperability technologies that improve patient care and allow providers to be more flexible and offer the most complete access to solutions.
Dr. Martha Rodriguez, founder of MMR Healthcare discusses interoperability and her firsthand experience of using data to improve both practice outcomes and patient experience. She talks about her use of eClinicalWorks who helps providers improve interoperability and have greater access to data, giving them access to live data, giving them access to Carequality and CommonWell Health Alliance networks, and securely exchanging over 50 million records per month with other practices and hospitals.
Dr. Stephanie Culler, Ph.D., co-founder and CEO of Persephone Biosciences discusses their VOICES (Vaccine Observation to Include all Communities for Equitable Science) study, a non-interventional, single-site study enrolling people in the U.S. being administered a COVID-19 vaccine. The goal is to identify and determine specific gut microbiota and the metabolic processes that are involved in an optimal immune response.